Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v1-EN
Language French English
Date Updated 2020-02-27 2017-03-15
Drug Identification Number 02212366 02212366
Brand name ZANTAC ZANTAC
Common or Proper name Ranitidine injection Ranitidine injection
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients RANITIDINE RANITIDINE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 2mL x 10's 10's
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Shortage of an active ingredient. Other (Please describe in comments)
Anticipated start date
Actual start date 2016-04-25 2016-03-08
Estimated end date Unknown
Actual end date 2018-08-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments This product has been discontinued. Stock depleted
Health Canada comments